Nbw Capital LLC Bristol Myers Squibb CO Transaction History

Nbw Capital LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $17,482 - $19,548	-302 Reduced 7.33%	3,819 $221,000
Q2 2023 Aug 15, 2023	BUY	$63.71 - $70.74 $29,943 - $33,247	470 Added 12.87%	4,121 $263,000
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $34,826 - $39,500	530 Added 16.98%	3,651 $253,000
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $213,726 - $253,081	3,121 New	3,121 $224,000
Q2 2022 Aug 01, 2022	SELL	$72.62 - $79.98 $209,218 - $230,422	-2,881 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$61.48 - $73.72 $177,123 - $212,387	2,881 New	2,881 $210,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Nbw Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Nbw Capital LLC with notifications on news.